CHU Brest - Hôpital Morvan

Brest, Finistere 29609

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, First Line Non-Small Cell Lung Cancer

Studies at this site

• DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] — Completed
• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] — Running, not enrolling
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed